المؤلفون: Chen W; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Jiang B; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Ruan Z; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Yang D; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Hu Y; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Lou H; Center of Clinical Pharmacology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. louhg@zju.edu.cn.

المصدر: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2024 Aug 26; Vol. 25 (1), pp. 57. Date of Electronic Publication: 2024 Aug 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Fasting* , Febuxostat*/pharmacokinetics , Febuxostat*/blood , Food-Drug Interactions* , Gout Suppressants*/pharmacokinetics , Gout Suppressants*/blood , Gout Suppressants*/administration & dosage , Models, Biological*, Adult ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Biological Availability ; Cross-Over Studies ; Therapeutic Equivalency ; White People ; East Asian People

المؤلفون: Guan M; Guangdong Provincial Key Laboratory of Food Quality and Safety/Nation-Local Joint Engineering Research Center for Machining and Safety of Livestock and Poultry Products, South China Agricultural University, Guangzhou 510642, China., Liu Z; Guangdong Provincial Key Laboratory of Food Quality and Safety/Nation-Local Joint Engineering Research Center for Machining and Safety of Livestock and Poultry Products, South China Agricultural University, Guangzhou 510642, China., Yu X; Sichuan Institute of Food Inspection, Chengdu 610097, China., Zhang S; National Nutrition Food Testing Center, Shenzhen Academy of Metrology and Quality Inspection, Shenzhen 518131, China., Huang X; Tropical Medicine Institute and South China Chinese Medicine Collaborative Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China., Lei H; Guangdong Provincial Key Laboratory of Food Quality and Safety/Nation-Local Joint Engineering Research Center for Machining and Safety of Livestock and Poultry Products, South China Agricultural University, Guangzhou 510642, China.; Guangdong Laboratory for Lingnan Modern Agriculture, Guangzhou 510642, China., Guan T; Guangdong Provincial Key Laboratory of Food Quality and Safety/Nation-Local Joint Engineering Research Center for Machining and Safety of Livestock and Poultry Products, South China Agricultural University, Guangzhou 510642, China.

المصدر: Journal of agricultural and food chemistry [J Agric Food Chem] 2024 Jul 31; Vol. 72 (30), pp. 17008-17016. Date of Electronic Publication: 2024 Jul 18.

نوع المنشور: Journal Article; Evaluation Study

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0374755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5118 (Electronic) Linking ISSN: 00218561 NLM ISO Abbreviation: J Agric Food Chem Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat*/analysis , Febuxostat*/chemistry , Food Contamination*/analysis , Functional Food*/analysis , Antibodies, Monoclonal*/chemistry, Immunoassay/methods ; Immunoassay/instrumentation ; Haptens/chemistry ; Haptens/immunology ; Animals

المؤلفون: Saito Y; Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba 260-0856, Japan., Tanaka A; Department of Cardiovascular Medicine, Saga University, Saga 849-8501, Japan., Yoshida H; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Japan., Nakashima H; Department of Cardiovascular Medicine, Imamura General Hospital, Kagoshima 890-0064, Japan., Ban N; Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba 260-0852, Japan., Matsuhisa M; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima 770-8503, Japan., Kobayashi Y; Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba 260-0856, Japan., Node K; Department of Cardiovascular Medicine, Saga University, Saga 849-8501, Japan., On Behalf Of The Prize Study Investigators

المصدر: Nutrients [Nutrients] 2024 Jul 19; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 19.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat*/therapeutic use , Febuxostat*/pharmacology , Hyperuricemia*/drug therapy , Hyperuricemia*/blood , Xanthine Oxidase*/antagonists & inhibitors , Lipids*/blood, Humans ; Male ; Female ; Middle Aged ; Aged ; Uric Acid/blood ; Gout Suppressants/therapeutic use ; Gout Suppressants/pharmacology ; Cholesterol, HDL/blood ; Carotid Artery Diseases/drug therapy ; Carotid Artery Diseases/blood ; Dyslipidemias/drug therapy ; Dyslipidemias/blood ; Glomerular Filtration Rate/drug effects

المؤلفون: Sakran W; Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Helwan University, Ain Helwan, POB 11795, Cairo, Egypt., Abdel-Hakim M; Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Helwan University, Ain Helwan, POB 11795, Cairo, Egypt., Teiama MS; Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Helwan University, Ain Helwan, POB 11795, Cairo, Egypt. dr_mteiama84@pharm.helwan.edu.eg.; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Galala University, Attaka, 43713, Suez, Egypt. dr_mteiama84@pharm.helwan.edu.eg., Abdel-Rashid RS; Pharmaceutics and Industrial Pharmacy Department, Faculty of Pharmacy, Helwan University, Ain Helwan, POB 11795, Cairo, Egypt.

المصدر: Drug delivery and translational research [Drug Deliv Transl Res] 2024 Jul; Vol. 14 (7), pp. 1909-1922. Date of Electronic Publication: 2024 Jan 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

مواضيع طبية MeSH: Solubility* , Febuxostat*/pharmacokinetics , Febuxostat*/chemistry , Febuxostat*/administration & dosage , beta-Cyclodextrins*/chemistry , beta-Cyclodextrins*/pharmacokinetics , beta-Cyclodextrins*/administration & dosage , Biological Availability* , Polyethylene Glycols*/chemistry , Polyethylene Glycols*/pharmacokinetics , Polyethylene Glycols*/administration & dosage, Animals ; Male ; Administration, Oral ; Water/chemistry ; Drug Liberation ; Rats, Sprague-Dawley ; Rats

المؤلفون: El-Shoura EAM; Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.; Department of Pharmacy Practice, Faculty of Pharmacy, Horus University in Egypt, New Damietta, Egypt., Sharkawi SMZ; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt., Abdelzaher LA; Department of Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt., Abdel-Wahab BA; Department of Pharmacology, College of Pharmacy, Najran University, Najran, Saudi Arabia., Ahmed YH; Department of Cytology and Histology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt., Abdel-Sattar AR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.

المصدر: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2024 Aug; Vol. 46 (4), pp. 509-520. Date of Electronic Publication: 2024 Jul 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8800150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2513 (Electronic) Linking ISSN: 08923973 NLM ISO Abbreviation: Immunopharmacol Immunotoxicol Subsets: MEDLINE

مواضيع طبية MeSH: Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/prevention & control , Acute Kidney Injury*/metabolism , Acute Kidney Injury*/pathology , Acute Kidney Injury*/drug therapy , Febuxostat*/pharmacology , NF-E2-Related Factor 2*/metabolism , NF-kappa B*/metabolism , Rats, Wistar* , Signal Transduction*/drug effects , Vancomycin*/toxicity , Vancomycin*/pharmacology, Animals ; Male ; Rats ; AMP-Activated Protein Kinases/metabolism ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/toxicity ; Cyclooxygenase 2/metabolism ; Heme Oxygenase (Decyclizing)/metabolism ; Kidney/drug effects ; Kidney/pathology ; Kidney/metabolism ; Oxidative Stress/drug effects ; PPAR gamma

المؤلفون: Li C; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Wang Y; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China., Mu R; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Zhao J; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Yao Z; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Zhai J; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Jin Y; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Liu R; Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China., Liu D; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China., Hong K; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China., Jiang H; Department of Urology, Peking University First Hospital, Beijing, 100034, China. jianghui@bjmu.edu.cn.; Institute of Urology, Peking University, Beijing, 100034, China. jianghui@bjmu.edu.cn., Zhang Z; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China. zhezhang@bjmu.edu.cn.; Department of Urology, Peking University Third Hospital, Beijing, 100191, China. zhezhang@bjmu.edu.cn.

المصدر: Rheumatology international [Rheumatol Int] 2024 Jul; Vol. 44 (7), pp. 1245-1253. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-160X (Electronic) Linking ISSN: 01728172 NLM ISO Abbreviation: Rheumatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Allopurinol*/therapeutic use , Benzbromarone*/therapeutic use , Febuxostat*/therapeutic use , Febuxostat*/pharmacology , Gout*/drug therapy , Gout*/blood , Gout Suppressants*/therapeutic use , Gout Suppressants*/adverse effects , Spermatozoa*/drug effects, Adolescent ; Adult ; Humans ; Male ; Middle Aged ; Young Adult ; Prospective Studies ; Semen Analysis ; Sperm Count ; Sperm Motility/drug effects ; Uric Acid/blood

المؤلفون: Yang XH; Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.; Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, China., Zhang BL; The Institutes of Biomedical Sciences (IBS), Fudan University, Shanghai, China., Cheng Y; Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China., Fu SK; Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China., Jin HM; Department of Nephrology, Shanghai Pudong Hospital, Fudan University, Pudong Medical Center, Shanghai, China.; Department of Nephrology, The People's Hospital of Wenshan Prefecture, Yunnan Province, China.

المصدر: Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2332956. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8906388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2060 (Electronic) Linking ISSN: 07853890 NLM ISO Abbreviation: Ann Med Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat*/therapeutic use , Febuxostat*/pharmacology , Glomerular Filtration Rate*/drug effects , Gout*/drug therapy , Gout*/complications , Gout Suppressants*/therapeutic use , Hyperuricemia*/drug therapy , Hyperuricemia*/complications , Randomized Controlled Trials as Topic*, Humans ; Creatinine/urine ; Creatinine/blood ; Disease Progression ; Kidney/physiopathology ; Kidney/drug effects ; Kidney Failure, Chronic/prevention & control ; Kidney Failure, Chronic/complications

المؤلفون: Barry A; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Helget LN; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Androsenko M; VA Boston Cooperative Studies Program Coordinating Center, Boston, Massachusetts., Wu H; VA Boston Cooperative Studies Program Coordinating Center, Boston, Massachusetts, and Babson College, Wellesley, Massachusetts., Kramer B; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Newcomb JA; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Brophy MT; VA Boston Cooperative Studies Program Coordinating Center and VA Boston Health Care System, Boston University, Boston, Massachusetts., Davis-Karim A; VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, New, Mexico., England BR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Ferguson R; VA Boston Cooperative Studies Program Coordinating Center and Boston University School of Medicine, Boston, Massachusetts., Pillinger MH; VA New York Harbor Health Care System and New York University Grossman School of Medicine, New York, New York., Neogi T; Boston University School of Medicine, Boston, Massachusetts., Palevsky PM; VA Pittsburgh Health Care System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Merriman TR; University of Alabama at Birmingham., O'Dell JR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska., Mikuls TR; Veterans Affairs (VA) Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Oct; Vol. 76 (10), pp. 1552-1559. Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat*/therapeutic use , Febuxostat*/administration & dosage , Allopurinol*/therapeutic use , Allopurinol*/administration & dosage , Gout Suppressants*/therapeutic use , Gout Suppressants*/administration & dosage , Gout*/drug therapy , Gout*/blood , Symptom Flare Up*, Humans ; Male ; Female ; Middle Aged ; Double-Blind Method ; Aged ; Uric Acid/blood ; Proportional Hazards Models

المؤلفون: King A; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK., Maisey T; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK., Harris EL; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK., Poulter JA; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK., Jayne DG; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK., Khot MI; School of Medicine, University of Leeds, St James University Hospital, Leeds, LS9 7TF, UK. M.I.Khot2@bradford.ac.uk.; School of Chemistry and Biosciences, University of Bradford, Bradford, BD7 1DP, UK. M.I.Khot2@bradford.ac.uk.; Richmond Building, School of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford, Bradford, BD7 1DP, UK. M.I.Khot2@bradford.ac.uk.

المصدر: Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology [Photochem Photobiol Sci] 2024 Jun; Vol. 23 (6), pp. 1067-1075. Date of Electronic Publication: 2024 Apr 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 101124451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-9092 (Electronic) Linking ISSN: 1474905X NLM ISO Abbreviation: Photochem Photobiol Sci Subsets: MEDLINE

مواضيع طبية MeSH: ATP Binding Cassette Transporter, Subfamily G, Member 2*/metabolism , ATP Binding Cassette Transporter, Subfamily G, Member 2*/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily G, Member 2*/genetics , Anthracenes*/pharmacology , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/metabolism , Colorectal Neoplasms*/pathology , Photochemotherapy* , Perylene*/analogs & derivatives , Perylene*/pharmacology , Febuxostat*/pharmacology , Febuxostat*/therapeutic use , Neoplasm Proteins*/metabolism , Neoplasm Proteins*/antagonists & inhibitors , Photosensitizing Agents*/pharmacology , Photosensitizing Agents*/chemistry, Humans ; HEK293 Cells ; Cell Survival/drug effects ; HT29 Cells ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry

المؤلفون: Takeshita M; Department of Cardiovascular Medicine, Saga University., Tanaka A; Department of Cardiovascular Medicine, Saga University., Yoshida H; Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine., Nakamura I; Department of Cardiovascular Medicine, Saga-Ken Medical Centre Koseikan., Shibata Y; Department of Cardiology, Miyazaki Medical Association Hospital., Hata S; Department of Cardiology, Sasebo City General Hospital., Kushiyama A; Department of Pharmacotherapy, Meiji Pharmaceutical University., Okutsu M; Department of Cardiovascular Medicine, New Tokyo Hospital., Ishizu T; Department of Cardiology, Faculty of Medicine, University of Tsukuba., Node K; Department of Cardiovascular Medicine, Saga University.

المصدر: Journal of atherosclerosis and thrombosis [J Atheroscler Thromb] 2024 Jun 01; Vol. 31 (6), pp. 864-875. Date of Electronic Publication: 2024 Jan 13.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Japan Atherosclerosis Society Country of Publication: Japan NLM ID: 9506298 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-3873 (Electronic) Linking ISSN: 13403478 NLM ISO Abbreviation: J Atheroscler Thromb Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat*/therapeutic use , Febuxostat*/pharmacology , Hyperuricemia*/drug therapy , Hyperuricemia*/blood , Xanthine Oxidase*/antagonists & inhibitors, Humans ; Male ; Female ; Middle Aged ; Leukocyte Count ; Prospective Studies ; Gout Suppressants/therapeutic use ; Aged ; Biomarkers/blood ; Follow-Up Studies ; C-Reactive Protein/metabolism ; C-Reactive Protein/analysis ; Uric Acid/blood